We narrowed to 213 results for: pme i

...ever since there were plasmids to share. Back when I was in the lab, if you read a paper and saw an interesting...Hooper, PhD, has also worked with R&D for product development and now specializes in supporting Promega cellular...

...gang, Mesik, L., Liang, F., Tao, H. W., & Zhang, L. I. (2017). AAV-Mediated Anterograde Transsynaptic Tagging...vivo. Molecular Therapy - Methods & Clinical Development, 3, 16062. https://doi.org/10.1038/mtm.2016.62...

...that antibodies can be used for a lot of purposes! I hope you appreciate how many types of antibodies are...reagent sharing platform for antibodies, the Developmental Studies Hybridoma Bank Learn more about nanobodies...

...crRNAs that bind to the template strand. Therefore, I suggest that picking a crRNA complementary to the ...manipulation of mammalian neural stem cells. Development 144: 635-648. PubMed PMID: 28096221. PubMed Central...

...Friedman, N., Brown, T. M., Lipscombe, D., Moore, C. I., Hochgeschwender, U., & Shaner, N. C. (2024). Efficient..., J. M., Gautam, D., Scarselli, M., Ruiz de Azua, I., Li, J. H., Rosemond, E., Ma, X., Gonzalez, F. J....., Mimura, K., English, J. G., Liu, J., Inoue, K. I., Kumata, K., Seki, C., … Minamimoto, T. (2020). Deschloroclozapine..., L. M., Lambert, G. G., Lipscombe, D., Moore, C. I., Shaner, N. C., & Hochgeschwender, U. (2024). Engineering...attractive targets for development into chemogenetic tools. Studies of GPCRs led to development of mutated receptors...

...Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996). In vivo gene delivery and... H., Yu, E. Y., An, D. S., Sabatini, D. M., Chen, I. S., Hahn, W. C., Sharp, P. A., Weinberg, R. A., &....2192803 PMID: 12649500 Timms, R. T., Tchasovnikarova, I. A., & Lehner, P. J. (2018). Differential viral accessibility...understand integration sites have led to the development of multiple genome-wide analysis pipelines to...barcoding libraries . Mouse Modeling Since the development of safer lentiviral vectors, they have been seen...differences. Molecular Therapy — Methods & Clinical Development , 21 , 451–465. https://doi.org/10.1016/j.omtm...sites. Molecular Therapy — Methods & Clinical Development , 20 , 792–800. https://doi.org/10.1016/j.omtm...

...Ramakrishnan, C., Mattis, J., Prakash, R., Diester, I., Goshen, I., Thompson, K. R., & Deisseroth, K. (2010). ...Davidson, T. J., O'Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., Stehfest, K., Fudim... novel ChRs from other algal species and the development of synthetic variants to enhance the functionality...channelrhodopsin variants: features, limitations and future developments. Exp Physiol, 96 (1), 19–25. https://doi.org...

.../doi.org/10.1038/nchembio.1753 Richter F, Fonfara I, Bouazza B, Schumacher CH, Bratovič M, Charpentier...Dalvie NS, Panda A, Fleming HE, Bhatia SN (2016) Development of Light-Activated CRISPR Using Guide RNAs with...

...., Podrebarac, D. M., Greenough, W. T., & Weiler, I. J. (2008). The use of total protein stains as loading...that each type of transfer requires different equipment. Wet transfers can be done in an insert in your...

....2022.12.006 PMID: 36620071 Mirow, M., Schwarze, L. I., Fehse, B., & Riecken, K. (2021). Efficient pseudotyping...lead to activation of the oncogene and possible development of cancer. Pseudotyping Tropism dictates which...manufacturing. Molecular Therapy — Methods & Clinical Development , 28 , 116–128. https://doi.org/10.1016/j.omtm...

...hsp70 ALS, motor neuron disease Caren Norden 105971 pME mKate2-dynactin1-811 DCTN1 mKate2 ALS, motor neuron...CMV, P10 Huntington's Cheryl Arrowsmith 112205 pBS-I-Sce1-eno2:Tau-IRES-egfp MAPT GFP, eno2 eno2 Parkinson's...Spinocerebellar Ataxia Richard Youle 176464 pVPS13D-I-EGFP VPS13D GFP CMV Spinocerebellar Ataxia Richard...

...Watanabe, M., Nishikawaji, Y., Kawakami, H., & Kosai, K. I. (2021). Adenovirus biology, recombinant adenovirus...verified, and linearized with the restriction enzyme PmeI . This construct is then transformed into AdEasier...cassette in one single viral particle. Vaccine Development rAdV vectors are highly immunogenic because they...

...PMID: 12663794 (Link opens in a new window) Kwon, I., & Schaffer, D. V. (2008). Designer gene delivery...be limited to small transgenes, enabling the development of further AAV applications. Read our blog post...opens in a new window) Merten, O. W. (2024). Development of stable packaging and producer cell lines for...